Offenbach, Germany

Gerhard Nössner


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gerhard Nössner: Innovator in Therapeutic Phospholipid Derivatives

Introduction

Gerhard Nössner is a notable inventor based in Offenbach, Germany. He has made significant contributions to the field of therapeutic treatments, particularly through his innovative work with phospholipid derivatives. With a total of two patents to his name, Nössner's research focuses on addressing critical health issues.

Latest Patents

Nössner's latest patents include methods for using therapeutic phospholipid derivatives. One patent describes a method of treating protozoal and fungal diseases by administering an effective amount of a compound of formula I to a host suffering from such diseases. Another patent outlines methods for treating bone marrow damage, which involves administering a compound of formula I to a host experiencing damage due to cytostatic agents or other myelotoxic active ingredients.

Career Highlights

Throughout his career, Nössner has been associated with Asta Medica, Aktiengesellschaft, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for patients with challenging health conditions.

Collaborations

Nössner has collaborated with esteemed colleagues, including Bernhard Kutscher and Wolfgang Schumacher. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Gerhard Nössner's contributions to the field of therapeutic phospholipid derivatives highlight his commitment to improving health outcomes through innovative research. His patents reflect a dedication to addressing significant medical challenges, making him a valuable figure in the realm of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…